PNC Financial Services Group Inc. Has $645,000 Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

PNC Financial Services Group Inc. grew its position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 928.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 156,997 shares of the company's stock after acquiring an additional 141,729 shares during the period. PNC Financial Services Group Inc. owned about 0.14% of Definitive Healthcare worth $645,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of DH. M&T Bank Corp grew its stake in Definitive Healthcare by 99.2% in the 4th quarter. M&T Bank Corp now owns 97,877 shares of the company's stock valued at $402,000 after buying an additional 48,746 shares during the last quarter. Bank of New York Mellon Corp grew its stake in Definitive Healthcare by 35.9% in the 4th quarter. Bank of New York Mellon Corp now owns 229,143 shares of the company's stock valued at $942,000 after buying an additional 60,559 shares during the last quarter. Ieq Capital LLC acquired a new position in Definitive Healthcare in the 4th quarter valued at about $51,000. New York State Common Retirement Fund grew its stake in Definitive Healthcare by 3.2% in the 4th quarter. New York State Common Retirement Fund now owns 771,792 shares of the company's stock valued at $3,172,000 after buying an additional 23,815 shares during the last quarter. Finally, Principal Financial Group Inc. grew its stake in Definitive Healthcare by 9.7% in the 4th quarter. Principal Financial Group Inc. now owns 43,960 shares of the company's stock valued at $181,000 after buying an additional 3,874 shares during the last quarter. Institutional investors own 98.67% of the company's stock.

Remove Ads

Definitive Healthcare Price Performance

Shares of Definitive Healthcare stock traded up $0.02 on Friday, reaching $2.81. 1,804,109 shares of the stock were exchanged, compared to its average volume of 759,435. The firm's 50 day moving average is $4.19 and its 200-day moving average is $4.31. Definitive Healthcare Corp. has a one year low of $2.55 and a one year high of $8.35. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The firm has a market cap of $317.28 million, a PE ratio of -0.91, a P/E/G ratio of 4.06 and a beta of 1.51.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by ($0.04). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The firm had revenue of $62.29 million for the quarter, compared to the consensus estimate of $60.60 million. As a group, analysts anticipate that Definitive Healthcare Corp. will post 0.16 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently commented on the stock. Stephens assumed coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an "equal weight" rating and a $5.00 price target on the stock. The Goldman Sachs Group decreased their price target on shares of Definitive Healthcare from $4.50 to $3.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 4th. Needham & Company LLC reiterated a "hold" rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Finally, Barclays cut their price objective on shares of Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a report on Monday, March 3rd. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $5.35.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.